A world where scientific innovations made possible through biotechnology conquer disease, sustain our environment, and healthfulness. To offer affordable, safe and effective healthcare solutions to combat mankind’s dreaded illnesses and to thus eradicate or at least control their occurrence in the years to come
We seek to address the health care needs of the billion people in the emerging markets by driving innovation and being a frontrunner in research and development of new vaccines and bio-therapeutics. To advance biotechnology innovation by promoting sound public policy and fostering collaboration, both locally and globally.
TIBER was founded in 2012 by North American University in Houston, Texas, USA. TIBER set up different platforms. The same platform can be be applied to different fields
VACCINE PLATFORM: (mRNA vaccine - Recombinant Antigen Vaccine):
- Vaccine For Microorganism: TIBER is a biotechnology institute of North American University Houston Texas, USA I that develops technologies and vaccines that stimulate and strengthens the immune system through active immunization by mRNA vaccine and viral recombinant antigen vaccine to fight against any kind of infection such as Covid-19. TIBER specializes in mRNA vaccines and recombinant protein nanoparticle vaccines for use in the treatment of several infectious diseases, such as the Covid-19.
- Vaccine For Cancer Immunotherapy: And also, the same platform can be applied to fight against cancer (Cancer Immunotherapy) through active immunization by mRNA vaccine or recombinant antigen vaccine to against organ or cancer specific antigens.
Chimeric T-cell Antigen (CAR) :
- CAR For Cancer Treatment: CAR is first-in-class therapeutics in order to treat serious life-threatening cancers such as acute myeloid leukemia (AML) through Chimeric T-cell Antigen (CAR) technique in T-cell or National Killer Cell (NK-cell)
- CAR For Autoimmune Disease Treatment: CAR is also, to engage in discovering, developing, manufacturing and marketing therapies for treating autoimmune disorders and neurodegenerative diseases such as Multiple Sclerosis (MS), in the United Sates as well as Internationally.
(TIBER)-3 IN SILICO DRUG SCREEN
TIBER is a Research Institute specialized also in screening and developing anti-disease drugs. For cancer treatment through anti cancer drugs or viral infection treatment through anti-viral drugs
- Drug Screening For Cancer Treatment: Screening and Discovering anti-vascular (anti-VEGF) and anti-GLUT-1 drugs (inhibitors) to use for cancer treatment through in silico drug screening.
- Anti Viral Screening For Covid-19: Screening and Discovering Anti –RdRp of SARS Co-2 drugs or Anti-RBD of SARS Co-2 drugs to treat patients who were infected by SARS Co-2.
SCREENING AND DEVELOPING HUMAN NEUTRALIZING ANTIBODIES FOR COVID-19 TREATMENT
TIBER is a Research Institute specialized also in screening and developing human neutralizing antibodies through molecular biology techniques in vitro. Neutralizing antibodies defend healthy cells by interfering with the biological function of an invading virus. These antibodies may be used therapeutically to treat someone currently fighting the disease and can be given to people who have heightened risk of exposure to SARS-CoV-2, such as healthcare workers.
Vaccinesheefa startup company operates in the field of prototype and serial production of COVID and CANCER vaccines, which are developed in universities, research centers, laboratories in the USA.
The Vaccinesheefa startup company aims to collaborate with investors to develop vaccine work.
WE CAN SEND PROPOSAL TO THOSE WHO WANT TO INVEST IN THE VACCINESEEFA STARTUP COMPANY WITH THE NCDA CONTRACT BELOW.
Contact: [email protected]